BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16809563)

  • 1. Impairment of dilator responses of cerebral arterioles during diabetes mellitus: role of inducible NO synthase.
    Kitayama J; Faraci FM; Gunnett CA; Heistad DD
    Stroke; 2006 Aug; 37(8):2129-33. PubMed ID: 16809563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-targeted mice reveal a critical role for inducible nitric oxide synthase in vascular dysfunction during diabetes.
    Gunnett CA; Heistad DD; Faraci FM
    Stroke; 2003 Dec; 34(12):2970-4. PubMed ID: 14657549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles.
    Gericke A; Goloborodko E; Sniatecki JJ; Steege A; Wojnowski L; Pfeiffer N
    Exp Eye Res; 2013 Apr; 109():60-6. PubMed ID: 23434456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats.
    Trauernicht AK; Sun H; Patel KP; Mayhan WG
    Stroke; 2003 Nov; 34(11):2698-703. PubMed ID: 14563973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrobiopterin rescues impaired responses of cerebral resistance arterioles during type 1 diabetes.
    Mayhan WG; Arrick DM
    Diab Vasc Dis Res; 2017 Jan; 14(1):33-39. PubMed ID: 27941054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes.
    Didion SP; Lynch CM; Baumbach GL; Faraci FM
    Stroke; 2005 Feb; 36(2):342-7. PubMed ID: 15637328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral vascular dysfunction during hypercholesterolemia.
    Kitayama J; Faraci FM; Lentz SR; Heistad DD
    Stroke; 2007 Jul; 38(7):2136-41. PubMed ID: 17525390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits.
    Lund DD; Faraci FM; Miller FJ; Heistad DD
    Circulation; 2000 Mar; 101(9):1027-33. PubMed ID: 10704171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type II diabetic rats.
    Schwaninger RM; Sun H; Mayhan WG
    Life Sci; 2003 Nov; 73(26):3415-25. PubMed ID: 14572882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.
    Terata K; Coppey LJ; Davidson EP; Dunlap JA; Gutterman DD; Yorek MA
    Br J Pharmacol; 1999 Oct; 128(3):837-43. PubMed ID: 10516670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of dilator responses of cerebral arterioles by extracellular superoxide dismutase.
    Kitayama J; Yi C; Faraci FM; Heistad DD
    Stroke; 2006 Nov; 37(11):2802-6. PubMed ID: 17008608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus.
    Mayhan WG; Simmons LK; Sharpe GM
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H319-26. PubMed ID: 1825454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus.
    Mayhan WG; Arrick DM; Sharpe GM; Patel KP; Sun H
    Microcirculation; 2006; 13(7):567-75. PubMed ID: 16990215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitric oxide synthase isoforms for ophthalmic artery reactivity in mice.
    Laspas P; Goloborodko E; Sniatecki JJ; Kordasz ML; Manicam C; Wojnowski L; Li H; Patzak A; Pfeiffer N; Gericke A
    Exp Eye Res; 2014 Oct; 127():1-8. PubMed ID: 25017185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of nitric oxide produced by inducible nitric oxide synthase to vascular responses of mesenteric arterioles in streptozotocin-diabetic rats.
    Ishikawa T; Kohno F; Kawase R; Yamamoto Y; Nakayama K
    Br J Pharmacol; 2004 Jan; 141(2):269-76. PubMed ID: 14707030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes-induced cerebrovascular dysfunction: role of poly(ADP-ribose) polymerase.
    Arrick DM; Sharpe GM; Sun H; Mayhan WG
    Microvasc Res; 2007 Jan; 73(1):1-6. PubMed ID: 16982071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral endothelial dysfunction in diabetes: intravital microscopic analysis using streptozotocin-induced diabetic rats.
    Jariyapongskul A; Patumraj S; Niimi H
    Clin Hemorheol Microcirc; 2003; 29(3-4):331-5. PubMed ID: 14724358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes.
    Schnackenberg CG; Wilcox CS
    Kidney Int; 2001 May; 59(5):1859-64. PubMed ID: 11318957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cerebral vascular dysfunction in Mn-SOD-deficient mice.
    Faraci FM; Modrick ML; Lynch CM; Didion LA; Fegan PE; Didion SP
    J Appl Physiol (1985); 2006 Jun; 100(6):2089-93. PubMed ID: 16514005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats.
    Nakazawa T; Kaneko Y; Mori A; Saito M; Sakamoto K; Nakahara T; Ishii K
    Vascul Pharmacol; 2007 Mar; 46(3):153-9. PubMed ID: 17079193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.